Review
ABSTRACT
Presently, nanotechnology appears as a powerful and innovative tool in the medical field. It has various advantages over the conventional drug therapy such as therapeutic specificity, has less side effects, reduces dose of drug, has more precise treatment and can access the inaccessible areas of the body like brain, tumor cells, etc. The human brain is the most complicated part of the body which is highly protected with the blood-brain barrier (BBB) and the other protective measures of the body. The available treatments for brain disorder are highly invasive (parenteral or surgical procedures) in nature or cause high peripheral toxicity (oral administration). Thus, a prominent strategy is needed which can easily approach the brain and offers a more specific treatment. Nanomedicines are effective tools used for the diagnosis and treatment of brain disorders.
Key words: Brain, neurodegenerative disorders, nanotechnology, gold nanoparticle, quantum dots.
INTRODUCTION
The brain is the most delicate, complex and vital organ of the human body. It regulates all the responses and stores information (Sonali et al., 2018). Our brain makes us feel, sense and be aware of every little sense and stimulusoutside as well as inside the body.The body has its protective measures to shield the brain from any damage. Among these, the very first protective structure is the skull which covers the whole brain and protects it from external injuries. The other primary protective layers include the meninges, blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier (Tsou et al., 2017). Throughout life, our brain comes in contact with various types of stimuli which sometimes harm the integrity and function of brain. The brain disorders may vary from accidental injury, shock, trauma, stroke from poisoning, infection, physiological dysfunctioning, genetic disorders, aging, etc. which damage any particular part or group of neurons (Orive et al., 2009). Concerning the treatment of brain disorder, medical science still has not any answer to brain disorders. There are some factors associated with brain physiology which restrict the therapy. A significant factor is the presence of physiological barriers like BBB which limits the entry of almost all the external molecules (including drug and nutrients) to the brain. Such protective feature makes the brain inaccessible to the drug and diagnostic aids (Blanco et al., 2015). Hence, the treatment needs a large dose of the drug to attain the therapeutic level that causes a systemic side effect. Along with this, the other treatment strategy includes surgical procedures or intracerebroventricular injections, a highly invasive and painful approach (Silva Adaya et al., 2017).
Considering such challenges, researchers are continuously trying to find out a promising and convenient tool to deliver the drug to the brain without interfering with the efficacy of the drug. One such approach is nanotechnology, the engineered nano-sized tools that regulate and manipulate the physicochemical prospects of any material or device at the molecular level (Huang et al., 2017). Research proves that nanotechnology is a useful tool that can replace or improve the presently available drug therapies and modify the diagnostic aids by using molecular imaging and modeling (Fan and Yeh, 2014; Silva et al., 2017; Sonali et al., 2018). The nanotherapeutics utilize various nanocarrier systems like liposome, nanoparticle, nanogels, dendrimer, nanotube, nanofiber, etc. and different targeting strategies to enhance the specificity of the treatment (Saraiva et al., 2016; Agrawal et al., 2017; Tsou et al., 2017; Poupot and Bergozza, 2018). The significant advantage of nanotechnology firstly involves its ability to deliver the drug across the BBB (Blanco et al., 2015), owing to the smaller size, secondly, the controlled and sustained release behavior (Saraf et al., 2015), thirdly, the targeting ability and lastly the ability to protect the drug integrity (Silva Adaya et al., 2017). Along with this, nanocarriers are highly stable, able to carry both the lipophilic and hydrophilic molecules and biodegradable in nature (Alexander et al., 2016; Kumar et al., 2017). This behavior makes nanocarrier a suitable tool for accessing the brain (Hassanzadeh et al., 2017). This novel technology is not only limited to the oral and parenteral administration, but it can also be given through topical, transdermal and intranasal route to the brain. By this way, it offers a non-invasive treatment over the painful parenteral and highly invasive surgical measures.
ADVANCED NANO-TOOLS
For the effective treatment and diagnosis of brain disorders, some advanced form of nanomaterials is presently under investigation like gold nanoparticle, carbon nanotube, a magnetic nanoparticle, silicon nanowires, etc.
Silicon nanowires
Silicon nanowires are a semiconductor nanowire made of silicon precursors. These are quasi-1D structures with a size of approximately 100 nm. The small size of the nanowires offers a larger surface area. Its unique mechanical, optical and electronic properties, biocompatibility and low toxicity profile makes it a promising therapeutic and diagnostic tool. Moreover, owing to the high surface-volume ratio, the silicon nanowires are used in biotechnology, for development of nanosensor, high-performance silicon nanoprobes, nanowires, etc. for biological investigation and recognition and treatment of various brain disorders (Peng et al., 2014). Also, the fluorescence silicon nanowires can be used for identification and imaging of tumor or cancer cells, detection of plaque formation, and recognition of DNA and proteins. Parmeshwaran et al. (2018) have developed a photosensitive silicone nanowire to modulate the neuronal activity and regulate cellular excitability in a non-genetic and non-invasive manner. The nanowires are administered in a drug like fashion and get activated inside the body by absorbing light (Lanzani, 2018). The study shows the nanotool as an effective and alternative approach over highly invasive surgical procedures for the treatment of brain disorders (Parameswaran et al., 2018).
Gold nanoparticle
Another important strategy is the gold nanoparticle which is now popular in neuroscience. These are nanosized colloidal particles made of gold, having a size of less than 100 nm and offer multiple surface functionalization (Kerdi et al., 2010). Due to the high surface functionality, it can easily interact with different antibiotics, proteins and oligonucleotides, thus, can serve as a promising diagnostic tool. It can also bind with targeting ligands and can cargo various drug substances, hence, used as a potential drug carrier (Brown et al., 2010). These are the potential oxidizing catalyst of liquid and gases. Thus, a suitable stabilizer or chemical method is needed to stabilize nanoparticles (Kerdi et al., 2010). It offers various advantages like drug targeting, cell signaling, nerve modulation, and signaling, etc. The application of gold nanoparticle in the treatment of neurological disorders includes neuro suppression (Yoo et al., 2014), nerve depolarization (Eom et al., 2014; Yong et al., 2014), neuromodulation by interfering with intracellular calcium signaling (Paviolo et al., 2014; Nakatsuji et al., 2015), neurite outgrowth enhancement (Paviolo et al., 2013; Papastefanaki et al., 2015). Along with this, gold nanoparticles are also used for gene therapy (Paviolo and Stoddart, 2017)
Carbon nanotubes
Carbon nanotubes were firstly prepared by Sumio Iijima in 1991, from the arc discharge of graphite electrode in an experiment (Iijima, 1991). The carbon nanotubes are entirely made of carbon atoms, arranged as a benzene ring; these benzene ring-like structures are made as graphene sheet which further turns into a cylindrical shape. By the arrangement, the carbon nanotubes are of two types (i) single-walled carbon nanotube and (ii) multi-walled carbon nanotube. The single-walled carbon nanotube consists of a single graphene sheet and having a cylinder diameter of less than 2.5 nm; while the multi-walled carbon nanotube is made of 2 or more graphene sheets with a cylindrical diameter up to 100 nm (Silva Adaya et al., 2017). The unique structure of the carbon nanotube is attributed to the high tensile strength, semiconductor property, high thermal conductivity, sustainability to the high current density, high resilience, etc. Thus it can be used as scanning probes, nanosensors, gas sensors and various nano-electric devices for bioanalysis (Esawi and Farag, 2007). The carbon nanotubes possess excellent plasma membrane permeability (Pantarotto et al., 2004), high drug loading, intrinsic spectroscopic behavior, hence, found suitable in disease diagnosis, imaging, and application in biotechnology (Lin et al., 2004). Recently it is also proposed as a component of protein biosensor, DNA (Li et al., 2005; Allen et al., 2007)and as ion channel blocker (Manish et al., 2005).
Super paramagnetic iron oxide nanoparticles (SPIONs)
Owing to the unique magnetic behavior, the SPIONs can serve as a promising diagnostic and therapeutic tool for CNS disorders. Their magnetic properties and surface modification assist in the identification of tumor cells, lesions and other pathological factors of CNS disorders.
At the same time, they can be used as a potential drug carrier system which specifically delivers the drug to its target site (Krupa et al., 2014). The main advantage and sometimes limitation of the magnetic nanoparticle is the necessity of an external magnetic field. The SPIONs get activated by the application of an external magnetic field and are inactive in its absence. Such property offers a great control over drug release, targeting and imaging responses of SPION. The average size of the magnetic nanoparticle is approximately 100 nm (SPION), and the particles with size less than 50 nm are known as ultra-super paramagnetic iron oxide nanoparticle (USPION) (Corot et al., 2006; Lodhia et al., 2010). In the past decade, the USPION became more popular as diagnostic agent than the SPION due to its unique ability to be visualized in both T1-MRI sequence and T2-MRI sequence as hyperintense (bright) and hypointense (dark) signal, respectively (Bridot et al., 2007; Na et al., 2007; Pan et al., 2008). Due to its smaller size, USPION can be absorbed by tumor cells via phagocytosis. However, the surface modification with an antibody or specific ligands could increase the targeting efficiency (Hadjipanayis et al., 2010). In addition, the USPION is a more patient-friendly carrier system with very less or no renal side effects (Neuwelt et al., 2007; Neuwelt et al., 2009).
Quantum dots
Quantum dots are one of the most studies nanotools nowadays. These are nano-sized crystalline colloidal semiconductor materials commonly consist of metallic crystals like selenium, cadmium, etc. At the core, they are enclosed by inert metal shell like zinc sulfide. These are the inorganic nanomaterials with high brightness, greater photostability and easy tunability to the narrow emission spectra. Such properties make them a promising diagnostic and therapeutic tool (Li et al., 2017). They are broadly used in biolabelling, biosensors, lasers, light emitting diodes and in the medical field for diagnosis as well as in therapy. In general quantum dots are fluorescent nanocrystals made of semiconductor materials which continuously emit energy. Because of the light emission property, quantum dots are found very useful in biological diagnosis and imaging (Silva Adaya et al., 2017).
Nanotechnology generally deals with the formulation of nano-sized particles or carrier system used for delivery of drug to treat various diseases. The NIH (National Institute of Health) of USA approved nanomedicines for diagnostic and therapeutic application (Markman et al., 2013). The nanocarriers have great advantages over conventional therapies and diagnosis techniques. They are easy to prepare by adopting standard techniques, can provide target specific action or recognition by surface functionalization with specific ligands. Moreover, the radiolabelled or fluorescent probes or other nano-sized devices offer a significant degree of monitoring and produce more precise results (Sonali et al., 2018). Also, they are biocompatible and can be used as a component of various biotechnological devices, DNA, protein and can offer ease of permeation across the biological membranes like BBB. The radiolabelled nanoparticles, nanoprobes, magnetic nanoparticle, gold nanoparticle, photoresponsive nanomaterials, surface modified (with a biomarker, ligand or specific antibody) nanoparticle represent an efficient and non-invasive method of diagnosis (Viola et al., 2015). However, their application is limited due to their toxicity profile and unpredictable in vivo response of these devices.
INTRANASAL APPROACH AS AN ALTERNATIVE ROUTE FOR BRAIN DRUG DELIVERY
One more interesting strategy is the nose-to-brain delivery of nanoparticle. The intranasal route directly delivers the drug to the brain through the olfactory route and bypasses the BBB. By this way, it enhances the drug efficacy, brain targeting and reduces the dose of the drug and systemic side effect. The amalgamation of nanotechnology with the intranasal route improves the retention time of drug in the nasal cavity, protects the drug from enzymatic degradation and target the drug to a particular part of the brain. Hence, the delivery of nanomedicines via nasal route offers an attractive, non-invasive and cost-effective therapy for brain disorders (Sonvico et al., 2018).
CONCLUSION
In this work, we have discussed a few examples of nanotools used as a diagnostic and therapeutic tool for brain disorders. There are a wide number of different nanotechnological approaches available for application or under research which overcomes the limitation of the conventional medical system. It offers a very convenient, more precise and quality services in the healthcare system. Although. some pitfalls are also there like the toxicity profile of nanomedicines which restricts the clinical application of such a prominent tool. Some of the nanomedicines were approved by the FDA for commercial application as anti-cancer drugs, analgesic agents and many more. Although, most of the works are in the pipeline. On the basis of the extensively successful research attempts, we the evidence of nanotechnology will be the next era of medical science.
ACKNOWLEDGEMENT
The authors want to acknowledge the Rungta College of Pharmaceutical Sciences and Research, Kohka-Kurud Road, Bhilai, Chhattisgarh, India for providing the necessary facilities for the compilation of the work. We also want to show our gratitude to the Patel College of Pharmacy, Bhopal, Madhya Pradesh, India for providing the necessary literature; to the Deanship of Scientific Research and their helpful team of employees at Taibah University, Al-Madinah Al-Munawarah, Kingdom of Saudi Arabia for their support.
CONFLICT OF INTERESTS
The authors have not declared any conflict of interests.
REFERENCES
Agrawal M, Ajazuddin DK, Tripathi S, Saraf S, Saraf SG, Antimisiaris S, Mourtas M, Hammarlund U, Alexander A (2017). Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease. Journal of controlled release 260:61-77 |
|
Alexander A, Ajazuddin RJ, Patel S, Saraf, Saraf S (2016). Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives. Journal of controlled release 241:110-124. |
|
Allen BL, Kichambare PD, Star A (2007). Carbon nanotube field-effect-transistor-based biosensors. Advanced Materials 19(11):1439-1451. Available from |
|
Blanco E, Shen H, Ferrari M (2015). Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nature Biotechnology 33(9):941-951. |
|
Bridot JL, Faure AC, Laurent S, Riviere C, Billotey C, Hiba B, Janier M, Josserand V, Coll JL, Elst LV, Muller R, Roux S, Perriat P, Tillement O (2007). Hybrid gadolinium oxide nanoparticles: Multimodal contrast agents for in vivo imaging. Journal of the American Chemical Society 129(16):5076-5084. |
|
Brown SD, Nativo P, Smith JA, Stirling D, Edwards PR, Venugopal B, Flint DJ, Plumb JA, Graham D, Wheate NJ (2010). Gold nanoparticles for the improved anticancer drug delivery of the active component of oxaliplatin. Journal of the American Chemical Society 132(13):4678-4684. |
|
Corot C, Robert P, Idee JM, Port M (2006). Recent advances in iron oxide nanocrystal technology for medical imaging. Advanced drug delivery reviews 58(14):1471-1504. |
|
Eom K, Kim J, Choi JM, Kang T, Chang JW, Byun KM, Jun SB, Kim SJ (2014).Enhanced infrared neural stimulation using localized surface plasmon resonance of gold nanorods. Small 10(19):3853-3857. |
|
Esawi AMK, Farag MM (2007). Carbon nanotube reinforced composites: Potential and current challenges. Materials and Design 28(9):2394-2401. Available from |
|
Fan CH, Yeh CK (2014).Microbubble-enhanced focused ultrasound-induced blood-brain barrier opening for local and transient drug delivery in central nervous system disease. Journal of Medical Ultrasound, 22(4):183-193. |
|
Hadjipanayis CG, Machaidze R, Kaluzova M, Wang L, Schuette AJ, Chen H, Wu X, Mao H (2010). Egfrviii antibody-conjugated iron oxide nanoparticles for magnetic resonance imaging-guided convection-enhanced delivery and targeted therapy of glioblastoma. Cancer research 70(15):6303-6312. |
|
Hassanzadeh P, Atyabi F, Dinarvand R (2017). Application of modelling and nanotechnology-based approaches:The emergence of breakthroughs in theranostics of central nervous system disorders. Life sciences 182:93-103. |
|
Huang L, Hu J, Huang S, Wang B, Siaw-Debrah F, Nyanzu M, Zhang Y, Zhuge Q (2017). Nanomaterial applications for neurological diseases and central nervous system injury. Progress in neurobiology, 157:29-48. |
|
Iijima S (1991). Helical microtubules of graphitic carbon. Nature 354(6348):56. |
|
Kerdi F, Caps V, Tuel A (2010). Innovative preparation of au/c by replication of gold-containing mesoporous silica catalysts. In: Studies in surface science and catalysis, E. M. Gaigneaux, M. Devillers, S. Hermans, P. A. Jacobs, J. A. Martens and P. Ruiz, (Eds.). Elsevier: pp. 221-224. |
|
Krupa P, Rehak S, Diaz-Garcia D, Filip S (2014). Nanotechnology - new trends in the treatment of brain tumors. Acta Medica (Hradec Kralove) 57(4):142-150. |
|
Kumar H, Gothwal A, Khan I, Nakhate KT, Alexander A, Ajazuddin V, Singh U, Gupta (2017). Galactose-anchored gelatin nanoparticles for primaquine delivery and improved pharmacokinetics: A biodegradable and safe approach for effective antiplasmodial activity against p. Falciparum 3d7 and in vivo hepatocyte targeting. 14(10):3356-3369. |
|
Lanzani G (2018). Light touch. Nature Nanotechnology 13(3):181-182. |
|
Li J, Liu Q, Liu Y, Liu S, Yao S (2005). DNA biosensor based on chitosan film doped with carbon nanotubes. Analytical Biochemistry 346(1):107-114. |
|
Li X, Tsibouklis J, Weng T, Zhang B, Yin G, Feng G, Cui Y, Savina IN, Mikhalovska LI, Sandeman SR, Howel CA, Mikhalovsky SV (2017) Nanocarriers for drug transport across the blood-brain barrier. Journal of drug targeting 25(1):17-28. |
|
Lin Y, Taylor S, Li H, Fernando KAS, Qu L, Wang W, Gu L, Zhou B, Sun YP (2004). Advances toward bioapplications of carbon nanotubes. Journal of Materials Chemistry 14(4):527-541. Available from http://dx.doi.org/10.1039/B314481J. |
|
Lodhia J, Mandarano G, Ferris N, Eu P, Cowell S (2010). Development and use of iron oxide nanoparticles (part 1): Synthesis of iron oxide nanoparticles for mri. Biomedical imaging and intervention journal 6(2):12. |
|
Manish C, Unalan HE, Yubing W, Zafar I, KiHo P, Federico S (2005). Irreversible blocking of ion channels using functionalized single-walled carbon nanotubes. Nanotechnology 16(12):2982. Available from http://stacks.iop.org/0957-4484/16/i=12/a=042. |
|
Markman JL, Rekechenetskiy A, Holler E, Ljubimova JY (2013). Nanomedicine therapeutic approaches to overcome cancer drug resistance. Advanced drug delivery reviews 65(13-14):1866-1879. |
|
Na HB, Lee JH, An K, Park YI, Park M, Lee IS, Nam DH, Kim ST, Kim SH, Kim SW, Lim KH, Kim KS, Kim SO, Hyeon T (2007). Development of a t1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angewandte Chemie 119(28):5493-5497. Available from https://onlinelibrary.wiley.com/doi/abs/10.1002/ange.200604775. |
|
Nakatsuji H, Numata T, Morone N, Kaneko S, Mori Y, Imahori H, Murakami T (2015). Thermosensitive ion channel activation in single neuronal cells by using surface-engineered plasmonic nanoparticles. Angewandte Chemie (International ed. in English), 54(40):11725-11729. |
|
Neuwelt EA, Hamilton BE, Varallyay CG, Rooney WR, Edelman RD, Jacobs PM, Watnick SG (2009). Ultrasmall superparamagnetic iron oxides (USPIOS): A future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney international 75(5): 465-474. |
|
Neuwelt EA, Varallyay CG, Manninger S, Solymosi D, Haluska M, Hunt MA, Nesbit G, Stevens A, Jerosch-Herold M, Jacobs PM, Hoffman JM (2007). The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: A pilot study. Neurosurgery 60(4):601-611 |
|
Orive G, Anitua E, Pedraz JL, Emerich DF (2009). Biomaterials for promoting brain protection, repair and regeneration. Nature reviews. Neuroscience 10(9):682-692. |
|
Pan D, Caruthers SD, Hu G, Senpan A, Scott MJ, Gaffney PJ, Wickline SA, Lanza GM (2008). Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets. Journal of the American Chemical Society 130(29):9186-9187. |
|
Pantarotto D, Singh R, McCarthy D, Erhardt M, Briand JP, Prato M, Kostarelos K, Bianco A (2004). Functionalized carbon nanotubes for plasmid DNA gene delivery. Angewandte Chemie 43(39):5242-5246. |
|
Papastefanaki F, Jakovcevski I, Poulia N, Djogo N, Schulz F, Martinovic T, Ciric D, Loers G, Vossmeyer T, Weller H, Schachner M, Matsas R (2015). Intraspinal delivery of polyethylene glycol-coated gold nanoparticles promotes functional recovery after spinal cord injury. Molecular therapy 23(6):993-1002. |
|
Parameswaran R, Carvalho-de-Souza JL, Jiang Y, Burke MJ, Zimmerman JF, Koehler K, Philips AW, Yi J, Adams E, Bezanilla F, Tian B (2018). Photoelectrochemical modulation of neuronal activity with free-standing coaxial silicon nanowires. Biophysical Journal 114(3, Supplement 1):393a. |
|
Paviolo C, Haycock JW, Cadusch PJ, McArthur SL, Stoddart PR (2014). Laser exposure of gold nanorods can induce intracellular calcium transients. Journal of Biophotonics 7(10):761-765. |
|
Paviolo C, Haycock JW, Yong J, Yu A, Stoddart PR, McArthur SL (2013). Laser exposure of gold nanorods can increase neuronal cell outgrowth. Biotechnology and Bioengineering, 110(8): 2277-2291. |
|
Paviolo C, Stoddart PR (2017). Gold nanoparticles for modulating neuronal behavior. Nanomaterials 7(4):92. |
|
Peng F, Su Y, Zhong Y, Fan C, Lee ST,He Y (2014). Silicon nanomaterials platform for bioimaging, biosensing, and cancer therapy. Accounts of chemical research 47(2):612-623. |
|
Poupot R, Bergozza D (2018). Nanoparticle-based strategies to treat neuro-inflammation. Materials 11(2):270. |
|
Saraf S, Gupta A, Alexander A, Khan J, Jangde M, Saraf S (2015). Advancements and avenues in nano phytomedicines for better pharmacological responses. Journal of nanoscience and nanotechnology 15(6):4070-4079. |
|
Saraiva C, Praca, R. Ferreira, T. Santos, L. Ferreira, and L. Bernardino (2016). Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. Journal of controlled release 235:34-47. |
|
Silva Adaya D, Aguirre-Cruz L, Guevara J, Ortiz-Islas E (2017). Nanobiomaterials' applications in neurodegenerative diseases. Journal of biomaterials applications 31(7):953-984. |
|
Sonali MK. Viswanadh RP, Singh P, Agrawal AK, Mehata DM, Pawde N, Sonkar R, Muthu MS (2018). Nanotheranostics: Emerging strategies for early diagnosis and therapy of brain cancer. Nanotheranostics 2(1):70-86. |
|
Sonvico F, Clementino A, Buttini F (2018).Surface-modified nanocarriers for nose-to-brain delivery: From bioadhesion to targeting.Pharmaceutics 10(1)34. |
|
Tsou YH, Zhang XQ, Zhu H, Syed S, Xu X (2017). Drug delivery to the brain across the blood-brain barrier using nanomaterials. Small 13(43). |
|
Viola KL, Sbarboro J, Sureka R, De M, Bicca MA, Wang J, Vasavada S, Satpathy S, Wu S, Joshi H, Velasco PT, MacRenaris K, Waters EA, Lu C, Phan J, Lacor P, Prasad P, Dravid VP, Klein WL (2015). Towards non-invasive diagnostic imaging of early-stage Alzheimer's disease. Nature nanotechnology 10(1): 91-98. |
|
Yong J, Needham K, Brown WG, Nayagam BA, McArthur SL, Yu A, Stoddart PR (2014). Gold-nanorod-assisted near-infrared stimulation of primary auditory neurons. Advanced healthcare materials, 3(11):1862-1868. |
|
Yoo S, Hong S, Choi Y, Park JH, Nam Y (2014). Photothermal inhibition of neural activity with near-infrared-sensitive nano transducers. ACS Nano 8(8):8040-8049. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0